Ivy Rx review

Ivy Rx is one of the few here that sells the microdose as its own product rather than a smaller amount of a weight-loss plan, and it prices it below its own full-dose GLP-1. Inside the microdose plan the price is the same at every dose, so a lower starting dose does not cost less than a higher one. Both figures it shows are "from" prices, and neither page says which molecule or billing term they buy, so the exact amount is only confirmed once you start the online visit. A clinician reviews the questionnaire the same day, orders run month to month with no long-term commitment, labs are not required, and delivery is free. Everything it sells today is a weekly injection, and there is no included registered-dietitian support. Compounded GLP-1 also sits in a contracting, enforcement-heavy post-shortage legal space.

Vs median

$100/mo below the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Ivy Rx says it uses a 503B outsourcing facility, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

An online questionnaire is reviewed by a clinician the same day, then compounded semaglutide or tirzepatide ships free as a weekly injection. Ivy Rx sells the microdose as its own product, from $69 a month for four doses, against from $77 for its full-dose GLP-1, and both pages say the price is the same at every dose. That makes the microdose cheaper than the standard plan but flat within itself: a low starting dose costs what a higher one does. The figures are "from" prices, and neither page says which molecule or billing term they buy, so the exact amount is only confirmed in the online visit. Orders are monthly with no long-term commitment, labs are not required, and the treatments are compounded in pharmacies the company describes as compliant with 503B/USP <797> standards.

Both figures are "from" prices, and neither page says which molecule or billing term they buy

• One price at every dose inside the microdose plan, so a lower dose within it does not cost less
• Injection only: no tablet or sublingual GLP-1 is sold today
• Compounded GLP-1s are not FDA-approved and sit in a contracting, enforcement-heavy post-shortage legal space
• No included registered-dietitian support in the base offering

Ivy Rx is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Is it still legal?
• Microdose & reconstitution calculator
• Titration planner